Medtronic Warms To Cryoablation With $380 Million Acquisition Of CryoCath

Medtronic gains a stake in the race to get the first FDA approval of an ablation catheter for atrial fibrillation with its $380 million acquisition of Montreal-based CryoCath, announced Sept. 25